These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 24633445)
1. Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome. Fujinaga S; Hara T Pediatr Nephrol; 2014 Jul; 29(7):1291-2. PubMed ID: 24633445 [No Abstract] [Full Text] [Related]
2. Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Kamei K; Okada M; Sato M; Fujimaru T; Ogura M; Nakayama M; Kaito H; Iijima K; Ito S Pediatr Nephrol; 2014 Jul; 29(7):1181-7. PubMed ID: 24500706 [TBL] [Abstract][Full Text] [Related]
3. The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome. Hirano D; Fujinaga S; Nishizaki N Clin Nephrol; 2012 Jun; 77(6):510-2. PubMed ID: 22595396 [No Abstract] [Full Text] [Related]
4. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab]. Huang J; Du J; Wang S; Xiao L; Zhao X Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):521-4. PubMed ID: 25224058 [TBL] [Abstract][Full Text] [Related]
5. Rituximab in the treatment of nephrotic syndrome: a systematic review. Otukesh H; Hoseini R; Rahimzadeh N; Fazel M Iran J Kidney Dis; 2013 Jul; 7(4):249-56. PubMed ID: 23880800 [TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome]. Yoshida M Nihon Jinzo Gakkai Shi; 2010; 52(1):1-9. PubMed ID: 20166533 [No Abstract] [Full Text] [Related]
13. Rituximab-induced serum sickness in a 6-year-old boy with steroid-dependent nephrotic syndrome. Nakamura M; Kanda S; Yoshioka Y; Takahashi C; Owada K; Kajiho Y; Harita Y; Oka A CEN Case Rep; 2020 May; 9(2):173-176. PubMed ID: 31970629 [TBL] [Abstract][Full Text] [Related]
14. Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Smith GC Pediatr Nephrol; 2007 Jun; 22(6):893-8. PubMed ID: 17310362 [TBL] [Abstract][Full Text] [Related]
15. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Guigonis V; Dallocchio A; Baudouin V; Dehennault M; Hachon-Le Camus C; Afanetti M; Groothoff J; Llanas B; Niaudet P; Nivet H; Raynaud N; Taque S; Ronco P; Bouissou F Pediatr Nephrol; 2008 Aug; 23(8):1269-79. PubMed ID: 18465150 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolate Mofetil Following Rituximab in Children With Steroid-Resistant Nephrotic Syndrome. Basu B; Mahapatra TK; Mondal N Pediatrics; 2015 Jul; 136(1):e132-9. PubMed ID: 26101364 [TBL] [Abstract][Full Text] [Related]
18. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab]. Kamei K; Okada M; Miyazono A; Sato M; Fujimaru T; Ogura M; Ito S Nihon Jinzo Gakkai Shi; 2013; 55(5):947-55. PubMed ID: 23980480 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab. Kamei K; Ishikura K; Sako M; Aya K; Tanaka R; Nozu K; Kaito H; Nakanishi K; Ohtomo Y; Miura K; Takahashi S; Morimoto T; Kubota W; Ito S; Nakamura H; Iijima K; Pediatr Nephrol; 2017 Nov; 32(11):2071-2078. PubMed ID: 28664242 [TBL] [Abstract][Full Text] [Related]